GUFIC BIOSCIENCES LTD. (GUFICBIO) financials

GUFIC BIOSCIENCES LTD. (GUFICBIO) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.

Market Cap: ₹4,056Cr.
Current Price: ₹404
Stock P/E: 55.2
ROE: 9.98%
ROCE: 12.2%
Book Value: ₹66.2
Dividend Yield: 0.02%
52W High / Low: ₹468/268

In Jun 2026, GUFIC BIOSCIENCES LTD. (GUFICBIO) reported sales ₹261 Cr and net profit ₹22 Cr.

Annual TTM: sales ₹974 Cr, net profit ₹74 Cr.

Shareholding: Promoters 72.50% (Sep 2026), FIIs 0.44% (Sep 2026), DIIs 3.38% (Sep 2026), Public 23.66% (Sep 2026), No. of Shareholders 29,726% (Sep 2026).

GUFICBIO quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	204	208	205	227	230	231	252	261
Expenses	166	174	178	195	195	195	206	214
Operating Profit	39	34	27	32	36	36	46	47
OPM %	19%	16%	13%	14%	16%	16%	18%	18%
Other Income	0	2	0	1	2	1	-1	0
Interest	5	5	8	9	10	8	9	9
Depreciation	4	5	8	8	8	8	8	8
Profit before tax	29	26	11	16	21	21	28	30
Tax %	26%	26%	26%	26%	27%	26%	26%	26%
Net Profit	22	19	8	12	15	16	21	22
EPS in Rs	2.17	1.93	0.79	1.20	1.49	1.55	2.05	2.24
Raw PDF	—	—	—	—	—	—	—	—

GUFICBIO profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	379	488	779	691	807	820	940	974
Expenses	327	404	631	556	657	683	790	810
Operating Profit	52	84	148	135	150	136	150	165
OPM %	14%	17%	19%	20%	19%	17%	16%	17%
Other Income	6	4	3	3	-0	4	3	2
Interest	14	14	5	8	17	25	37	37
Depreciation	14	16	19	22	17	21	31	31
Profit before tax	30	58	127	107	116	94	85	99
Tax %	25%	23%	24%	25%	26%	26%	26%	—
Net Profit	23	44	96	80	86	70	63	74
EPS in Rs	2.92	5.68	9.89	8.22	8.59	6.97	6.30	7.33
Dividend Payout %	2%	2%	1%	1%	1%	1%	2%	—

GUFICBIO balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	8	10	10	10	10	10	10	10
Reserves	68	120	164	259	338	523	591	654
Borrowings	98	126	62	64	334	333	336	405
Other Liabilities	106	152	157	188	179	227	232	273
Total Liabilities	280	408	392	521	861	1,093	1,170	1,342
Fixed Assets	24	83	100	115	160	159	506	491
CWIP	10	31	13	41	170	307	22	22
Investments	0	0	0	0	1	2	3	3
Other Assets	245	294	279	365	531	625	639	826
Total Assets	280	408	392	521	861	1,093	1,170	1,342

GUFICBIO cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	5	47	87	106	-27	-7	123	44
Cash from Investing Activity	-13	-43	-7	-95	-191	-102	-72	-31
Cash from Financing Activity	8	-4	-79	-6	234	82	-37	32
Net Cash Flow	-0	0	2	5	17	-27	14	45
Free Cash Flow	-8	7	75	19	-214	-116	52	13
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	33%	110%	115%	94%	1%	13%	107%	37%

GUFICBIO shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	72.51%	72.51%	72.51%	72.50%	72.50%	72.50%	72.50%	72.50%
FIIs	0.30%	0.31%	0.32%	0.33%	0.44%	0.42%	0.47%	0.44%
DIIs	2.99%	3.39%	3.38%	3.66%	3.74%	3.83%	3.67%	3.38%
Public	24.20%	23.79%	23.81%	23.51%	23.30%	23.23%	23.36%	23.66%
No. of Shareholders	33,299	31,844	31,876	31,420	30,362	29,223	29,753	29,726

GUFICBIO key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	107	103	93	71	109	149	140	115
Inventory Days	190	249	138	102	202	188	211	281
Days Payable	157	238	162	125	143	156	155	173
Cash Conversion Cycle	141	114	69	48	167	181	197	224
Working Capital Days	40	17	63	50	68	97	93	81
ROCE %	30%	21%	29%	46%	23%	17%	13%	12%

GUFICBIOUpdated 18 Oct 2026, 19:24

Gufic Biosciences Ltd.

GUFICBIOUpdated 18 Oct 2026, 19:24

Market Cap

₹4,056Cr.

Current Price

₹404

High / Low

₹468/268

Stock P/E

55.2

ROE9.98%

ROCE12.2%

Book Value₹66.2

Face Value₹1.00

Dividend Yield0.02%

About

Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	195	4	160	1	4	28	26	21	2.13
Sep 2023	215	4	176	0	4	31	25	23	2.39
Dec 2023	202	3	165	0	4	30	25	22	2.22
Mar 2024	195	4	161	1	4	27	26	20	2
Jun 2024	203	5	167	1	4	28	26	21	2.08
Sep 2024	204	5	166	0	4	29	26	22	2.17
Dec 2024	208	5	174	2	5	26	26	19	1.93
Mar 2025	205	8	178	0	8	11	26	8	0.79
Jun 2025	227	9	195	1	8	16	26	12	1.2
Sep 2025	230	10	195	2	8	21	27	15	1.49
Dec 2025	231	8	195	1	8	21	26	16	1.55
Mar 2026	252	9	206	-1	8	28	26	21	2.05
Jun 2026	261	9	214	0	8	30	26	22	2.24

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	148	4	134	1	4	7	36	4	0.54
Mar 2016	201	6	181	1	4	10	29	7	0.95
Mar 2017	245	6	222	1	4	14	37	9	1.17
Mar 2018	306	9	267	4	4	30	45	16	2.13
Mar 2019	351	10	305	4	5	35	38	22	2.82
Mar 2020	379	14	327	6	14	30	25	23	2.92
Mar 2021	488	14	404	4	16	58	23	44	5.68
Mar 2022	779	5	631	3	19	127	24	96	9.89
Mar 2023	691	8	556	3	22	107	25	80	8.22
Mar 2024	807	17	657	0	17	116	26	86	8.59
Mar 2025	820	25	683	4	21	94	26	70	6.97
Mar 2026	940	37	790	3	31	85	26	63	6.3
TTM	974	37	810	2	31	99	—	74	7.33

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	72.5%
FIIs	0.44%
DIIs	3.38%
Public	23.66%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	72.51%	0.47%	1.72%	—	25.29%
Mar 2024	72.51%	0.12%	2.2%	—	25.17%
Jun 2024	72.51%	0.23%	2.38%	—	24.89%
Sep 2024	72.51%	0.23%	2.51%	—	24.75%
Dec 2024	72.51%	0.3%	2.99%	—	24.2%
Mar 2025	72.51%	0.31%	3.39%	—	23.79%
Jun 2025	72.51%	0.32%	3.38%	—	23.81%
Sep 2025	72.5%	0.33%	3.66%	—	23.51%
Dec 2025	72.5%	0.44%	3.74%	—	23.3%
Mar 2026	72.5%	0.42%	3.83%	—	23.23%
Jun 2026	72.5%	0.47%	3.67%	—	23.36%
Sep 2026	72.5%	0.44%	3.38%	—	23.66%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	8	19	33	67	127	25	0	0	102	127
Mar 2016	8	26	43	75	152	22	0	0	130	152
Mar 2017	8	30	57	84	178	22	0	0	156	178
Mar 2018	8	46	80	104	238	23	2	0	213	238
Mar 2019	8	68	98	106	280	24	10	0	245	280
Mar 2020	10	120	126	152	408	83	31	0	294	408
Mar 2021	10	164	62	157	392	100	13	0	279	392
Mar 2022	10	259	64	188	521	115	41	0	365	521
Mar 2023	10	338	334	179	861	160	170	1	531	861
Mar 2024	10	523	333	227	1093	159	307	2	625	1093
Mar 2025	10	591	336	232	1170	506	22	3	639	1170
Mar 2026	10	654	405	273	1342	491	22	3	826	1342

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	11	-2	-5	4
Mar 2016	-4	-1	5	0
Mar 2017	-4	-5	7	-1
Mar 2018	-5	-9	14	1
Mar 2019	5	-13	8	0
Mar 2020	47	-43	-4	0
Mar 2021	87	-7	-79	2
Mar 2022	106	-95	-6	5
Mar 2023	-27	-191	234	17
Mar 2024	-7	-102	82	-27
Mar 2025	123	-72	-37	14
Mar 2026	44	-31	32	45

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	82	102	78	97	107	103	93	71	109	149	140	115
Inventory Days	165	180	190	238	190	249	138	102	202	188	211	281
Days Payable	223	188	132	192	157	238	162	125	143	156	155	173
Cash Conversion Cycle	25	94	136	143	141	114	69	48	167	181	197	224
Working Capital Days	4	18	14	26	40	17	63	50	68	97	93	81
ROCE %	18%	24%	24%	33%	30%	21%	29%	46%	23%	17%	13%	12%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of GUFIC BIOSCIENCES LTD. (GUFICBIO)?

The reported market capitalisation for GUFIC BIOSCIENCES LTD. (GUFICBIO) is ₹4,056Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of GUFICBIO?

The current price shown for GUFIC BIOSCIENCES LTD. (GUFICBIO) on Fincrux is ₹404 with a 52-week high/low of ₹468/268.

What is the P/E ratio of GUFIC BIOSCIENCES LTD. (GUFICBIO)?

The stock P/E for GUFIC BIOSCIENCES LTD. (GUFICBIO) is 55.2 on Fincrux, with ROE at 9.98% and ROCE at 12.2%.

What were GUFICBIO latest quarterly results?

For Jun 2026, GUFIC BIOSCIENCES LTD. (GUFICBIO) reported sales ₹261 Cr and net profit ₹22 Cr (figures in ₹ crore unless noted).

What are GUFICBIO annual sales and net profit?

For TTM, GUFIC BIOSCIENCES LTD. (GUFICBIO) shows sales of ₹974 Cr and net profit of ₹74 Cr on the Fincrux profit & loss statement.

Who owns GUFIC BIOSCIENCES LTD. (GUFICBIO)?

Latest shareholding for GUFIC BIOSCIENCES LTD. (GUFICBIO) on Fincrux: Promoters 72.50% (Sep 2026), FIIs 0.44% (Sep 2026), DIIs 3.38% (Sep 2026), Public 23.66% (Sep 2026), No. of Shareholders 29,726% (Sep 2026).

Where can I find GUFIC BIOSCIENCES LTD. (GUFICBIO) financials?

GUFIC BIOSCIENCES LTD. (GUFICBIO) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show GUFICBIO balance sheet and cash flow?

Yes. The GUFIC BIOSCIENCES LTD. (GUFICBIO) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 19:24